Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
10x Genomics
(NASDAQ:TXG)
Intraday
$27.94
-1.01
[-3.49%]
After-Hours
$27.94
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$27.94
-1.01
[-3.49%]
At close: Apr 19
$27.94
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 11 days from now on Tue Apr 30th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for 10x Genomics Stock (NASDAQ:TXG)
10x Genomics Stock (NASDAQ: TXG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 18, 2024
The Analyst Landscape: 4 Takes On 10x Genomics
Benzinga Insights
-
1 day ago
Deutsche Bank Maintains Buy on 10x Genomics, Lowers Price Target to $55
Benzinga Newsdesk
-
1 day ago
Wednesday, April 10, 2024
Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $45
Benzinga Newsdesk
-
Apr 10, 2024, 3:38PM
Thursday, April 04, 2024
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade
Benzinga Neuro
-
Apr 4, 2024, 11:03PM
Tuesday, March 26, 2024
10x Genomics Launches Visium HD Spatial Gene Expression Assay
Benzinga Newsdesk
-
Mar 26, 2024, 9:06AM
Wednesday, March 13, 2024
10x Genomics Begins Commercial Shipments Of Chromium GEM-X Products
Benzinga Newsdesk
-
Mar 13, 2024, 4:11PM
Monday, March 04, 2024
Gold Breaks Above $2,110, Inches Closer To Record High, With Rallying Mining Stocks
Piero Cingari
-
Mar 4, 2024, 5:28PM
Thursday, February 29, 2024
Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
Benzinga Neuro
-
Feb 28, 2024, 11:02PM
Monday, February 26, 2024
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
Benzinga Neuro
-
Feb 26, 2024, 10:45PM
Thursday, February 22, 2024
Cathie Wood's Ark Invest Sells $6.6M Worth of Coinbase Shares While Crypto Exchange Grapples With Massive Bitcoin Drain
Benzinga Neuro
-
Feb 22, 2024, 12:52AM
Tuesday, February 20, 2024
Cathie Wood's Ark Invest Buys Over $25M Worth Of Roku Shares Amid Dip — Sells Crypto-Related Coinbase, Robinhood Stocks
Benzinga Neuro
-
Feb 20, 2024, 10:54PM
Friday, February 16, 2024
Cathie Wood's Ark Sells Coinbase Shares Amid Bitcoin Rally Despite Surprise Quarterly Profit — Nvidia, Alphabet Stocks Also Shed
Benzinga Neuro
-
Feb 16, 2024, 12:06AM
Thursday, February 15, 2024
10x Genomics Sees FY24 Revenue $670M-$690M Vs $702.06M Estimate
Benzinga Newsdesk
-
Feb 15, 2024, 4:49PM
10x Genomics: Q4 Earnings Insights
Benzinga Insights
-
Feb 15, 2024, 4:15PM
10x Genomics Q4 2023 Adj EPS $(0.24) Beats $(0.36) Estimate, Sales $183.98M Beat $182.80M Estimate
Benzinga Newsdesk
-
Feb 15, 2024, 4:11PM
Earnings Scheduled For February 15, 2024
Benzinga Insights
-
Feb 15, 2024, 5:17AM
Wednesday, February 14, 2024
Preview: 10x Genomics's Earnings
Benzinga Insights
-
Feb 14, 2024, 12:02PM
Monday, February 12, 2024
Cathie Wood-led Ark Invest Dives Into Pinterest Stock Amid Q4 Turbulence: Purchases Over $23M Worth
Benzinga Neuro
-
Feb 12, 2024, 9:35PM
Wednesday, February 07, 2024
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Benzinga Neuro
-
Feb 7, 2024, 10:20PM
Monday, February 05, 2024
Why Is Life Science Tools Firm NanoString Stock Trading Lower Today?
Vandana Singh
-
Feb 5, 2024, 8:30AM
Friday, February 02, 2024
Cathie Wood's Ark Invest Snatches Up $4.7M More In Tesla Shares, Invests Equally In This Rocket Company
Benzinga Neuro
-
Feb 1, 2024, 11:18PM
Thursday, January 25, 2024
Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $55
Benzinga Newsdesk
-
Jan 25, 2024, 9:38AM
Wednesday, January 17, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 17, 2024, 1:12PM
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
-
Jan 17, 2024, 11:18AM
Monday, January 08, 2024
10x Genomics Announces Preliminary Q4 Revenue $184M vs $179.7M Est., Prelim. 2023 Revenue $618.7M vs $614.69M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 9:13AM
Tuesday, December 19, 2023
Integrative Study Conducted By 10x Genomics Combines Single Cell, Spatial And In Situ Analyses To Investigate Tumor Invasiveness
Benzinga Newsdesk
-
Dec 19, 2023, 9:09AM
Thursday, December 14, 2023
10x Genomics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and a $60 price target.
Benzinga Newsdesk
-
Dec 14, 2023, 12:06PM
The Latest Analyst Ratings for 10x Genomics
Benzinga Insights
-
Dec 14, 2023, 10:00AM
Guggenheim Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $60
Benzinga Newsdesk
-
Dec 14, 2023, 5:59AM
Cathie Wood's Ark Invest Sells $42M Worth Of Coinbase Shares Even As Bitcoin, Ethereum Soar
Benzinga Neuro
-
Dec 13, 2023, 11:03PM
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On 10x Genomics with Outperform Rating
Benzinga Newsdesk
-
Dec 13, 2023, 12:03PM
Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
Benzinga Neuro
-
Dec 12, 2023, 11:22PM
Tuesday, December 12, 2023
B of A Securities Upgrades 10x Genomics: Here's What You Need To Know
Benzinga Insights
-
Dec 12, 2023, 12:00PM
B of A Securities Upgrades 10x Genomics to Neutral, Raises Price Target to $54
Benzinga Newsdesk
-
Dec 12, 2023, 7:27AM
Thursday, December 07, 2023
10x Genomics And NIH CARD To Create Comprehensive Single Cell Atlas Of The Human Brain
Benzinga Newsdesk
-
Dec 7, 2023, 9:03AM
Thursday, November 30, 2023
Cathie Wood's Ark Invest Continues to Jettison Coinbase Shares As Anticipation Builds Around Approval of Bitcoin Spot ETF
Benzinga Neuro
-
Nov 30, 2023, 10:56PM
Thursday, November 23, 2023
Chief Commercial Officer of 10x Genomics Sold $619K In Stock
Benzinga Insights
-
Nov 23, 2023, 10:04AM
Monday, November 20, 2023
Why Is Life Science Company NanoString Stock Trading Lower Today?
Vandana Singh
-
Nov 20, 2023, 11:29AM
Sunday, November 19, 2023
NanoString Comments On Delaware District Court Verdict; Says "We Respectfully Disagree With The Jury's Verdict, Which We Will Seek To Have Overturned Or Amended In Our Post-Trial Motions And Then Expect To Appeal To The U.S. Court Of Appeals"
Benzinga Newsdesk
-
Nov 19, 2023, 10:06PM
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies; Jury Awards 10x Genomics Over $31M In Damages And Finds All Seven Asserted Patents Valid And Willfully Infringed By NanoString
Benzinga Newsdesk
-
Nov 19, 2023, 3:34PM
Tuesday, November 14, 2023
Earnings Scheduled For November 14, 2023
Benzinga Insights
-
Nov 14, 2023, 8:23AM
Monday, November 13, 2023
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
Benzinga Neuro
-
Nov 13, 2023, 10:17PM
Thursday, November 09, 2023
Cathie Wood's Ark Invest Purchases $9.5M Worth Of Robinhood Shares, Downsizes Holdings Of Grayscale Bitcoin Investment Trust
Benzinga Neuro
-
Nov 8, 2023, 11:42PM
Thursday, November 02, 2023
10x Genomics Q3 EPS $(0.79), Sales $153.64M Beat $151.26M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 4:55PM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Monday, October 30, 2023
Cathie Wood's Ark Invest Scoops Up More Than $3M Worth Of SoFi Technologies Shares Amid Q3 Earnings Beat From Online Lender
Benzinga Neuro
-
Oct 30, 2023, 11:14PM
Wednesday, October 18, 2023
Cathie Wood's Ark Offloads $6.3M In Tesla Shares Amid EV Maker's Q3 Earnings Disappointment
Benzinga Neuro
-
Oct 18, 2023, 9:58PM
Tuesday, October 10, 2023
10x Genomics Comments On Second UPC Preliminary Injunction Decision After UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products In Europe Remain In Full Effect
Benzinga Newsdesk
-
Oct 10, 2023, 12:08PM
Friday, September 29, 2023
Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $47
Benzinga Newsdesk
-
Sep 29, 2023, 5:54AM
Tuesday, September 19, 2023
Where 10x Genomics Stands With Analysts
Benzinga Insights
-
Sep 19, 2023, 2:00PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch